Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: Walkingshadow who wrote (1031)	6/12/1999 10:51:00 PM
From: SDR-SI	Read Replies (2) \| Respond to of 1686

WS: From the BGEN website press release RE: AMEVIVE: > > >CAMBRIDGE, Mass., May 25 /PRNewswire/ -- Biogen (Nasdaq: BGEN) today announced that AMEVIVE(TM) (Recombinantly Engineered LFA-3/IgG1 Human Fusion Protein), its candidate for treatment of moderate-to-severe psoriasis, showed excellent dose response and side-effect profile in a Phase II clinical trial. The Company said it will proceed aggressively to begin Phase III registrational studies in North America and Europe after making further improvements in the commercial process.< < < The full release can be reviewed at: prnewswire.com Further, information on initial results of Antova as a rejection inhibitor for cellular transplantation (specifically in pancreatic cell transplantation in treatment of juvenile onset diabetes) was in many of the newspapers and on most of the TV networks earlier this week. Both of these products have numerous applications beyond those noted above; however, the market potential of each in just the above-cited indications is reasonably estimated at or above that of Avonex. It would appear that the problem with Biogen's pipeline may be in your level of knowledge of its details, rather than in the company's creative, successful and proven R&D operation. Steve P.S. The company has previously indicated that any eventual income from the farmout of Hirulog would essentially be "found money". I am pleased to see that you believe there will be some Hirulog income on the horizon.